BridgeBio Oncology Therapeutics Inc.
BBOT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $272 | $250 | $266 | $175 |
| - Cash | $409 | $32 | $1 | $2 |
| + Debt | $3 | $3 | $0 | $0 |
| Enterprise Value | -$134 | $221 | $265 | $173 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$49 | -$30 | -$23 | -$22 |
| % Margin | – | – | – | – |
| Net Income | -$45 | -$28 | -$22 | -$20 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.9 | 0.039 | -0.02 | 0.12 |
| % Growth | -4,959.3% | 295.5% | -116.7% | – |
| Operating Cash Flow | -$71 | -$23 | -$1 | -$0 |
| Capital Expenditures | -$1 | -$0 | $0 | $0 |
| Free Cash Flow | -$71 | -$24 | -$1 | -$0 |